| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Sjogren's Syndrome | |||||
| Xerostomia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Syndrome | |||||
| 3 | More general conditions related to this trial | ||||
| Arthritis | |||||
| Arthritis, Rheumatoid | |||||
| Autoimmune Diseases | |||||
| Connective Tissue Diseases | |||||
| Disease | |||||
| Dry Eye Syndromes | |||||
| Eye Diseases | |||||
| Immune System Diseases | |||||
| Joint Diseases | |||||
| Lacrimal Apparatus Diseases | |||||
| Mouth Diseases | |||||
| Musculoskeletal Diseases | |||||
| Pathologic Processes | |||||
| Rheumatic Diseases | |||||
| Salivary Gland Diseases | |||||
| Stomatognathic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Thalidomide | |||||
| 5 | More general drug interventions related to this trial | ||||
| Angiogenesis Inhibitors | |||||
| Angiogenesis Modulating Agents | |||||
| Anti-Bacterial Agents | |||||
| Anti-Infective Agents | |||||
| Antineoplastic Agents | |||||
| Growth Inhibitors | |||||
| Growth Substances | |||||
| Immunologic Factors | |||||
| Immunosuppressive Agents | |||||
| Leprostatic Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute of Dental and Craniofacial Research (NIDCR) | |||||
|
